Affiliation:
1. Kawakita General Hospital
2. Tokyo Institute of Technology
Abstract
The release property of osteoprotegerin (OPG) from hydroxyapatite / chondroitin sulphate (HAp/ChS) microparticles was described in this paper. The formulation was conducted by subsequent addition of zinc chloride solution into the mixture of HAp/ChS microparticles as a ceramic carrier and OPG solution. The release of OPG from the microparticles in PBS was positively correlated with soaking time without initial burst. The release rate of OPG was decreased with the increase of the amounts of zinc cation, which was not dependent of ChS wt% in the microparticles. The controlled release of OPG would provide the improvement of drug effect and the reduction of adverse effects. These findings reveal further investigation of the other antiresortive agents as a potential safer medication for osteoporosis.
Publisher
Trans Tech Publications, Ltd.
Subject
Mechanical Engineering,Mechanics of Materials,General Materials Science
Reference24 articles.
1. RANMARK (denosumab) [package insert]: Daiichi-Sankyo., (2012).
2. M. Tanaka et al. 16th Annual meetng of the Japan osteoporosis society (2013).
3. W. S. Simonet et al. Cell, 89 (1997) p.309–319.
4. T. Matsumoto et al. Biomaterials 25 (2004) pp.3807-3812.
5. Y. Mizushima et al. J. Controlled Release 110 (2006) pp.260-265.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献